Sikarin PCL

BKK-SKR
Stock Exchange of Thailand
Healthcare Medical Care Facilities
Global Rank
#14859
Country Rank
#134
Market Cap
430.22 M
Price
0.21
Change (%)
1.49%
Volume
142,820

Sikarin PCL's latest marketcap:

430.22 M

As of 06/13/2025, Sikarin PCL's market capitalization has reached $430.22 M. According to our data, Sikarin PCL is the 14859th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 430.22 M
Revenue (ttm) 186.95 M
Net Income (ttm) 19.5 M
Shares Out 2.05 B
EPS (ttm) 0.01
Forward PE 0.00
Ex-Dividend Date 04/29/2025
Earnings Date 08/08/2025
Market Cap Chart
Data Updated: 06/13/2025

Sikarin PCL's yearly market capitalization.

Sikarin PCL has seen its market value drop from ฿13 B to ฿430.22 M since 2020, representing a total decrease of 96.69% and an annual compound decline rate (CAGR) of 53.47%.
Date Market Cap Change (%) Global Rank
06/13/2025 ฿430.22 M -30.72% 14859
12/30/2024 ฿19.86 B -5.39% 12053
12/28/2023 ฿20.99 B -26.09% 11688
12/30/2022 ฿28.4 B 6.15% 9354
12/30/2021 ฿26.75 B 105.85% 10547
12/30/2020 ฿13 B 12391

Company Profile

About Sikarin Public Company Limited

Sikarin Public Company Limited, along with its subsidiaries, operates a network of hospitals in Thailand, providing comprehensive healthcare services across multiple specialties.

Core Services and Facilities

  • Specialized Centers: Diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, and children’s dental center.
  • Diagnostic & Treatment Units: Laboratory department, diagnostic radiology center, CT scan unit, and catheter laboratory.
  • Critical Care: Intensive care units, coronary care units, and inpatient wards including international wards.
  • Women’s & Pediatric Health: Woman’s health center, fertility center, delivery room, nursery department, and obstetrics & gynecology ward.
  • Additional Specialties: Stroke center, EENT center, orthopedics center, and MRI center.

Additional Business Operations

  • Management of rental spaces.
  • Sale of food and beverages.
  • Operation of restaurants and medical clinics.

Founded: 1979
Headquarters: Bangkok, Thailand

Frequently Asked Questions

  • What is Sikarin PCL's (BKK-SKR) current market cap?
    As of 06/13/2025, Sikarin PCL (including the parent company, if applicable) has an estimated market capitalization of $430.22 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Sikarin PCL global market capitalization ranking is approximately 14859 as of 06/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.